Empagliflozin vs Rabeprazole

Empagliflozin vs Rabeprazole: Overview

This comparison examines the pharmacological differences between Empagliflozin and Rabeprazole.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Rabeprazole: Proton pump inhibitor irreversibly inhibiting gastric H+/K+-ATPase with faster onset than omeprazole.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Rabeprazole — 1-2 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Rabeprazole — C18H21N3O3S.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Rabeprazole — 359.4440 g/mol.

Type: Empagliflozin — Small molecule; Rabeprazole — Small molecule.